A hope ahead of the day dedicated to this disease, next Monday.
The recent discovery of a link between multiple sclerosis and the Epstein-Barr virus suggests that a better response is possible in the long term, specialists point out.
Treatments, which aim to block inflammation, have "made great progress in the past ten years", and patient follow-up is "more individualized", told AFP neurologist Jean Pelletier, from the Arsep Foundation (Aide à la multiple sclerosis research).
He believes that new advances could come from a particularly important discovery, made in January by American researchers: the Epstein-Barr virus is necessary for the development of multiple sclerosis, even if all infected people do not develop the disease. sickness.
About 110,000 people affected in France
Multiple sclerosis is an autoimmune disease of the central nervous system (brain and spinal cord).
It causes a disruption of the immune system, which attacks myelin, the protective sheath of nerve fibers.
Most often, it causes inflammatory flare-ups interspersed with calm phases.
The disease is very variable from one patient to another but can lead to sequelae, and is one of the frequent causes of disability in young adults.
It is estimated that more than 2.8 million people are affected by this autoimmune disease worldwide (about 110,000 people in France).
Children and adolescents remain a minority of cases, but the disease may have started long before it can be diagnosed.
A vaccine as a solution?
The discovery of a link to the Epstein-Barr virus, which affects 95% of adults and causes other diseases such as mononucleosis, suggests that most cases of multiple sclerosis could be prevented by stopping infection with this pathogen.
In addition to "a better understanding of what may be involved in this multifactorial disease", the study "suggests that we could prevent multiple sclerosis from breaking out if we vaccinated children against the Epstein- Barr, knowing that we do not have a vaccine for the moment, ”according to Professor Pelletier.
“This famous Epstein-Barr virus, once contracted, it is hidden in our body in the B lymphocytes, themselves involved in the inflammatory reaction linked to multiple sclerosis.
This could explain in particular that certain treatments targeting B lymphocytes, monoclonal antibodies, have an extremely high efficacy against multiple sclerosis,” he said.
Sport
Paralympic Games: Suffering from multiple sclerosis, the Frenchwoman Cécile Hernandez crunches gold in snowboardcross
Company
Multiple sclerosis: A “where you are the hero” app to better understand the disease
Health
Research
Multiple sclerosis